6CNR
aducanumab apo Fab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 31-ID |
Synchrotron site | APS |
Beamline | 31-ID |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2008-10-10 |
Detector | MARMOSAIC 225 mm CCD |
Wavelength(s) | 0.987 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 143.311, 64.126, 67.293 |
Unit cell angles | 90.00, 95.85, 90.00 |
Refinement procedure
Resolution | 46.500 - 2.090 |
R-factor | 0.2122 |
Rwork | 0.211 |
R-free | 0.23900 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4lf3 |
RMSD bond length | 0.002 |
RMSD bond angle | 0.605 |
Data reduction software | HKL-2000 |
Data scaling software | SCALEPACK |
Phasing software | MOLREP |
Refinement software | PHENIX ((1.13_2998: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.160 |
High resolution limit [Å] | 2.090 | 2.090 |
Rmerge | 0.057 | 0.486 |
Number of reflections | 36105 | |
<I/σ(I)> | 20.3 | |
Completeness [%] | 99.3 | |
Redundancy | 3.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 297 | 19% PEG 3350 in 100 mM sodium acetate, and 300 mM lithium sulfate |